# Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction

> **NCT01088191** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 17 (actual)

## Conditions studied

- Anterior Cruciate Ligament Injury
- Osteoarthritis

## Interventions

- **BIOLOGICAL:** MSB-CAR001 Combined With Hyaluronan
- **DRUG:** Hyaluronan

## Key facts

- **NCT ID:** NCT01088191
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-11
- **Final completion:** 2014-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088191, "Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01088191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*